key: cord-0055274-uaimh2zs
authors: nan
title: 5. Interdisziplinärer Kongress „Quality of Cancer Care“ (QoCC 2021): der Deutschen Krebsgesellschaft (DKG) und der Arbeitsgemeinschaft Deutscher Tumorzentren (ADT), 20. Januar bis 19. Februar 2021
date: 2021-01-19
journal: Forum
DOI: 10.1007/s12312-020-00890-0
sha: 855c3fdac284881d6b7610116f683a0be7c07717
doc_id: 55274
cord_uid: uaimh2zs

nan

Background: Malignant tumors of the scalp are often characterized by an aggressive behavior and high risk of recurrence, and can lead to infiltration of the periosteum, calvarial bone, dura, and brain. Oncologic radicality is of important prognostic significance regarding local recurrence and overall mortality. Therefore, tumor resection of the scalp can result in complex wounds with challenging reconstructive prospects due to the inelasticity of the surrounding tissue, scalp convexity, and limited tissue expandability. Since malignant scalp tumors predominantly affect elderly patients with multiple comorbidities, the benefit of definitive single stage procedures (tumor resection and reconstruction) cannot be disregarded. Methods: This report describes two cases of locally advanced squamous cell carcinoma of the scalp which were treated by radical oncological surgery involving circular craniectomy followed by free latissimus dorsi muscle flap reconstruction. Follow-up visits were scheduled every 3 months and included clinical assessment as well as ultrasound of regional lymph nodes.

Results: The patients were 77 and 82 years old and had a medical history of arterial hypertension and kidney transplantation as well as coronary artery disease, cerebrovascular accident and hepatocellular carcinoma, respectively. One patient received a free latissimus dorsi flap without bone reconstruction due to the high parietal localization of the defect. The other patient presented with a large tumor on the frontal scalp. Therefore, bone reconstruction with Palacos cement was performed by the neurosurgeon. In both cases, there were no signs of dura infiltration. Final histopathology showed a complete resection of the squamous cell carcinoma infiltrating the calvarial bone. There were no major surgical complications and both patients were discharged 16 days after the operation. In the follow-up period of one year, no recurrence was detected. Discussion: Depending on the size, depth, and localization of the scalp tumor and resulting defect, the reconstruction can range from secondary healing, primary closure, skin grafting, or flap reconstruction. While secondary healing and primary closure are only applicable for small defects, local flaps can cover medium sized scalp defects. However, in some cases, the use of free flaps remains the only effective reconstructive option especially when previous radiation therapy or operations limit the use of local flaps. Free flaps have the advantage of transferring well-vascularized tissue from remote parts of the body that are outside the zone of injury. In cases of previous radiation or when adjuvant radiation therapy is indicated, free tissue transfer offers a more durable solution compared to skin grafts or local flaps. Research has shown that free flap scalp reconstruction is safe even in elderly patients who suffer from multiple comorbidities. Previously published treatment algorithms may facilitate the choice of technique for scalp reconstruction. Conclusion: Scalp reconstruction by free flaps can be considered as a safe and reliable curative therapeutic option for patients with locally advanced malignant scalp tumors. Rigorous preoperative assessment in an interdisciplinary team including dermatologists, neurosurgeons, and plastic surgeons is essential in order to reach good functional and aesthetical outcomes and minimize complications such as flap loss, donor site morbidity, and prolonged wound healing.

[100] Implementation of a health-economic analysis tool in a certified oncological centre offering integrative oncology concepts Background: Recent data reveal that integrative oncology ( IO) concepts involving standard of care and add-on complementary therapies are utilized to a high extent by oncological patients, may be effective in treatment and offer cost-saving options from the hospital's perspective. The EQ-5D-5L is a validated and internationally widely used instrument to study patientreported outcomes and in combination with survival data a perfect tool for health-economic calculations of e. g., quality-adjusted life years. The primary objective of the present prospective longitudinal study was to analyse whether the EQ-5D-5L can be implemented into the clinical routine of a German Cancer Society-certified oncological centre offering IO. Methods: The accredited Network Oncology ( NO) registry received an extension of the vote of the ethics committee to evaluate patient-reported outcomes with the EQ-5D-5L questionnaire in November 2018. EQ-5D-5L questionnaires were handed out to primary oncological patients of the certified oncological centre at first diagnosis (T0) as well as six months (T6) and 12 months (T12) after diagnosis. Only questionnaires with complete patient's answers at three consecutive time points (T0, T6, and T12) were analysed. Patient's data were retrieved from the NO registry; hospital's stationary cost details were obtained from the reimbursement database at the hospital of the oncological centre. Results: From November 2018 until September 2020 a total of 400 oncological patients signed the informed consent and answered the EQ-5D-5L. Questionnaires with complete answers for all three consecutive time points were available for 105 subjects at abstract submission. The median age of the patients was 65 years ( IQR: 55.8-72.6 years) with a female proportion of 76.2%. The majority of patients were breast cancer patients (53.3%) followed by lung (23.8%), gastrointestinal or other cancer patients (22.9%). The frequency of reported burden at diagnosis varied from 32.4% in selfcare to 68.8% in pain/discomfort, whereas only 12.3% of respondents reported no problems in any dimension of the questionnaire (11,111). Six months after diagnosis, the frequency of reported pain/discomfort of oncological patients increased by 7.6% while self-care burden decreased by a significant 20% (p < 0.001), both remaining at a constant level twelve months post-diagnosis.

The results of the present study reveal a possible implementation of the EQ-5D-5L questionnaire into the running routine care of a certified oncological centre, adding a helpful health-economic (n = 171/267) of them were male. Most of the patients had an ECOG status of 0 or 1 (77%; n = 206/267) and 86% of them were current or ex heavy smoker (n = 230/267). 77% (n = 206/267) of the patients that have been discussed in the multidisciplinary tumor board, were afterwards further treated at the same certified lung cancer center. In 77% (n = 206/267) of patients, the treatment recommendations from the multidisciplinary tumor boards were completely adhered to. There were different reasons for non-adherence, e. g., patient's wish, patient characteristics and death before starting therapy. The median overall survival for the 267 patients was 13 months. Patients with a complete adherence to the multidisciplinary tumor board recommendation had an overall survival of 16 months (n = 206) compared to 5 months (n = 31) for patients with a partial adherence compared to 1 months (n = 30) for patients with a non-adherent treatment (p < 0.000). Conclusion: Preliminary results give a hint to the fact that patients with an adherent treatment after first diagnosis had a longer overall survival than patients with another therapy. More cases will be presented at the meeting using a multivariate analysis which includes patient characteristics and healthcare organizations that took over further treatment as predictors. Furthermore, the findings can be used to design interventions that improve the adherence of multidisciplinary tumor board recommendations in outpatient oncology care, optimize the quality of care, and thus potentially make a significant contribution to the implementation of the German cancer plan.

[71] Leitlinienbasierte Qualitätsindikatoren für urologische Tumoren -Entwicklung und Implementierung Background: The rapid start of therapy is crucial for the prognosis of head and neck tumor patients. Studies have shown that by shortening the time between diagnosis and therapy initiation, survival and functional outcome can be significantly improved. In February 2020, a new concept of multidisciplinary work up of head and neck cancer patients was implemented in the University Hospital Zurich, Head and Neck Tumor Centre. The aim of the concept was to optimize the diagnostic work up and staging process in order to include all the necessary steps within three subsequent days including the interdisciplinary tumor board recommendation for the individual therapy. Furthermore, we aimed to reduce professional bias in therapy decisions by interdisciplinary evaluation of patients at first consultation. Aim of the project: We aimed to prove shortened time between diagnosis and start of therapy as well as increased efficiency in the pre-inpatient clarification. Additionally, we evaluated whether the new concept can save costs.

We included all primary tumor cases of the Head and Neck registered in the University Hospital Zurich, Zurich Switzerland, from 2019 and 2020 in our study. The patient cohort from 2019 (before introduction of the new clarification approach) was compared with the cohort after the start of the intake consultation in 2020. Results: 327 Patients with HNSCC treated in curative intent either surgically or radiotherapeutically at the University Hospital Zurich, Head and Neck Tumor Centre, were included in the study. The time-to-treatment interval was significantly lower in the fast track work up cohort than the conventional work up cohort. Total diagnostic costs were comparable in the 2 cohorts. Discussion: By increasing the efficiency of diagnostic workup, we save time, avoid redundancies, save costs (infrastructure, consultations), detect potential risk factors early on (delirium, malnutrition, social situation) and, last but not least, increase patient satisfaction. A versatile analysis of all combinations of demographic data as well as QI's allow the definition of outcome and quality parameters. Benchmarking among involved institutions, as well as on the international level become possible. Further, our efforts prove that the definition of QI's is possible and that these efforts need to be extended for each single discipline. Fazit: Such real-world data registry with the capacity to report on QI's paves the way to create a novel ecosystem for sarcoma patient care in the future. Background: Chronic lymphocytic leukemia ( CLL) is the most common leukemia of adults in western countries. The course of CLL varies and can be characterized from indolent to highly aggressive. Therapy is only indicated in symptomatic early and advanced stages. In recent years, the therapy of CLL has changed fundamentally. Since 2010, rituximab, an anti-CD20 antibody, has been approved for treatment of CLL, which until then had only been based on chemotherapy drugs. The aim of this work was to investigate survival in CLL before and after the introduction of combined chemoimmunotherapy in Germany at the population level. [118] Definition and assessment of quality indicators of sarcoma work-up using a transdisciplinary real-world digital data platform Hintergrund: Sarcomas belong to the rare diseases and its therapy requires a transdisciplinary approach of several disciplines. Overall progress has been rather slow mainly because each single discipline assesses their own data. The French sarcoma network has shown the power of a registry to define new treatment approaches. Further, Switzerland will inaugurate a new law in 2021 on assessing the quality in medicine. However, to be able to report on quality, the capacity of assessing real-world data is a prerequisite, as well as to have a common source of definition on the quality indicators of sarcoma work-up ( QI). Methoden: The Swiss Sarcoma Network ( SSN) created a real-world data platform (www.adjumed.net) by combining the management of the weekly sarcomaboard with the sarcoma registry. This platform allows the collection of patient data, the analysis of each parameter in every possible combination, as well as the validation through patient reported outcomes. The SSN has inaugurated an international advisory board of world renowned sarcoma experts, among others to define 18 QI's. These include eg. whether significantly more frequent in younger patients below 70 years (p-Value 0.011) and in right side tumors (p-Value 0.031) compared to the KRAS wildtype group. Fazit: In our real-life cohort we did not find a prognostic value for the KRAS p.G12C mutation in early Colon cancer stages, nor did the alteration show association with distinct clinical features.

[64] Neudiagnose Hodentumor: 30-Monats-Daten aus der nichtinterventionellen, prospektiven Registerstudie versus von d-uo (Deutsche Uro-Onkologen). The sample consisted of 1002 people with breast, prostate or colorectal cancer. In a questionnaire, participants indicated their pre-and post-diagnosis moderate-to-vigorous PA ( MVPA), their perception of physicians' exercise counseling as defined by the 5A framework (Assess, Advise, Agree, Assist, Arrange) and their satisfaction with exercise counseling. The association between exercise counseling and post-diagnosis PA was determined using a conditional process analysis, which further allowed to explore the mediating role of satisfaction with counseling at different levels of patients' pre-diagnosis PA. Ergebnisse: Almost half of the participants reported that their physician had assessed or advised PA, whereas more profound counseling steps of the 5A framework were only rarely reported. The analyses yielded a positive association between physicians' exercise counseling and patients' post-diagnosis MVPA. However, mediating pathways of this association differed by patients' pre-diagnosis MVPA (p = 0.039). While exercise counseling was directly related to higher post-diagnosis MVPA among the group with lowest pre-diagnosis MVPA levels ( CI:0.02-0.20, p = 0.014), the association was mediated through satisfaction with counseling for the group with highest pre-diagnosis MVPA levels (BootCI:0.01-0.08). Diskussion: Our results indicate that people with cancer might benefit from physician's exercise counseling, especially when adjusted to their previous PA behavior. The 5A framework provides a convenient approach to implement this into practice. In this context, structured plans for PA assessment, advise and referral as well as the establishment of interdisciplinary teams could help to engage physicians and successfully realize comprehensive exercise counseling in clinical routine.

Fazit: The present study shows that physicians' exercise counseling could help to increase PA among people with cancer and further highlights the importance of stepping away from unspecific exercise recommendations to more comprehensive counseling that is tailored to the patients' exercise experience.

[98] Youex-study implementation and evaluation of three exercise modules for young adults with cancer 

In the last two decades, an overwhelming body of scientific evidence has been established that displays the positive effects of physical activity and exercise for cancer patients [1] . However, the special interests of younger adults with cancer, including the integration of online-tools and social media in health care programs, are rarely considered in exercise interventions [2] . Hence, clinically validated digital media tools such as apps for the promotion of physical activity have not yet been developed for this target group; although, other supportive care disciplines are already working with digital media tools. Furthermore, there is barely any information available about the efficacy of digital media for the treatment of tumor and tumor-therapy-related side-effects such as cancer related fatigue ( CRF) or health related quality of life ( QoL) [3] .

Objective: The aim of this study is to offer three different physical activity modules, targeting the gap between existing exercise programs and digital media integration in health care. All three approaches will be evaluated with regards to their feasibility, moreover their efficacy on CRF, QoL and physical activity level ( PAL) is analyzed. Methods: This study is an explorative intervention of a 12-week exercise program for cancer patients aged 18-39 years who currently have or had a cancer diagnosis within the past 5 years. Eligible patients may choose between three exercise modules: M1: social media exercise program once a week, M2: independent training on an online-training platform, M3: participation in an in-person community-based exercise program close to their place of residence. The selected module can be replaced or amended by another module after 6 and 12 weeks. The aim is to recruit 70-80 patients over 8 months with a completion rate of at least 70%. The primary endpoints feasibility, module selection und completion rate as well as QoL and PAL as secondary endpoints are surveyed by questionnaires at four time points (T0: baseline, before exercise program, T1: after 6 weeks intervention; T2: after 12 weeks; Follow up T3: after 24 weeks). Further, a daily online fatigue diary observes the intra-and interindividual impact on fatigue-levels. Results: More patients preferred continent UD (n = 44) to incontinent UD (n = 22). A quarter of patients did not indicate a preference (n = 24). Patients who preferred continent UD were significantly younger and more conscientious than patients who preferred incontinent methods. Most patients expressed a low desire for autonomy in decision making. We found no differences for generic participation preference, but in the uro-oncological case vignettes patients who favored incontinent UD had a significantly higher participation preference. Patients did not differ in their reported state or trait anxiety, and only few reported severe anxiety levels. Interestingly, we found no correlation between anxiety and participation preference for generic or uro-oncological decision making. Discussion: Our findings provide novel insight into differences between patient-reported preference for UD. We identified conscientiousness and age as important factors. As expected, the desire for involvement in urooncological decision making was lower in patients who preferred continent UD. Interestingly, while other studies have shown patients' anxiety to influence decision making outcomes negatively, our results indicate that it may not be detrimental to patients' initial engagement in SDM.

In sum, our findings illustrate the importance of patient characteristics for treatment preferences and provide a valuable contribution to the SDM literature. Objective: Patient-centered care and shared decision making ( SDM) are generally recognized as the gold-standard for medical consultations. SDM is especially relevant for preference-sensitive decisions. Even though personality and mental health may influence a patient's ability to cope with a disease and its treatment, little is known about patient characteristics that influence treatment preferences. We set out to examine this for the choice of urinary diversion ( UD) after radical cystectomy in uro-oncological patients, as it is one of the most invasive surgical procedures and has significant, lifelong consequences for the patient. We were interested in aspects of patients' personality, anxiety, desire for autonomy in decision making, and socio-demographic characteristics. While incontinent methods of UD are considered more conservative and associated with lower risks, continent UD involves a more complex operating procedure. Thus, we expected more anxious and older individuals to prefer incontinent UD. We also expected patients who preferred incontinent UD to express a stronger desire for autonomy in decision making. As continent UD is often considered the primary option, patients who prefer incontinent methods may feel a stronger need to make their voices heard in the medical interaction.

In addition, we aimed to link increased anxiety to a lower desire for autonomy in decision making.

We recruited a sample of bladder cancer patients (N = 90, primarily male, retired) who awaited a medical consultation before a radical cystectomy in five participating tertiary care centers. Patients were asked to fill in a set of self-report questionnaires, including measures to assess patient preference for UD, personality ( BFI-10), anxiety ( STAI), and participation preference ( API generic and uro-oncological vignettes), as well as socio-demographic characteristics. 

Providerebene (direkt und indirekt beteiligte Mitarbeiter) und (3) Patientenebene. Das Ziel von Studie 1 konzentriert sich auf die tatsächliche Umsetzung (intervention fidelity) der interprofessionellen KMP-Beratungen in den jeweiligen CCCs. Dazu wird ein selbstentwickelter Fragebogen für die Erst-(5 Items) und Folgeberatungen (6 Items) aus der Perspektive der Patient*innen und Mitarbeiter*innen in den Interventionsmonaten 1, 6 und 12 eingesetzt und analysiert. Um zu beurteilen, ob die Intervention wie geplant durchgeführt wurde, werden Audioaufzeichnungen von mehreren Beratungen (n = 5-10) in jedem CCC qualitativ ausgewertet. Studie 2 zielt darauf ab, die Akzeptanz sowie Hemm-und Förderfaktoren für die Umsetzung der KMP-Beratungen in die Routineversorgung aus der Perspektive der Mitarbeiter*innen darzustellen. Die quantitative Erhebung umfasst die Bewertung der Interprofessionellen Sozialisation und Wertschätzung ( ISVS), der Interprofessionellen Zusammenarbeit ( AITCS-II), der Arbeitszufriedenheit ( WCW) und der Kompetenzen zu vier Zeitpunkten (T0 Baseline, T1 vor Beginn der Intervention, T2 Midline, T3 Ende der Intervention). Darüber hinaus findet nach der 13-tägigen Schulung, SD = 27.5; standard care: M = 43.1, SD = 29.9, p < 0.05, p = 0.033). No differences between the groups were found regarding secondary endpoints. Discussion: The most prevalent information needs for support of newly diagnosed lung cancer patients were adequately and timely addressed by the MCA. Patients with standard oncological care also received the information but delayed. The results of our study thus provide evidence that the communication approach is a method to address relevant issues along the disease trajectory. Conclusion: By addressing relevant issues at predefined times, the MCA is a tool to enhance early palliative care.

[82] Erhebung von Lebensqualität und Therapietreue via App bei Brustkrebs-Patientinnen: Prospektive, randomisierte, multizentrische Studie zum Effekt einer digitalen Softwareapplikation im Vergleich zur Standardbehandlung [113] Is there a benefit for adjuvant radio(chemo)therapy in early cervical cancer? Results from a population-based study

Results: A total of 306 patients had invasive-ductal carcinoma. Of these, 40 patients received CMS, 82 TRE, and 184 no further excision. After comparing these subgroups in a binary regression model there was a tendency for CMS and TRE to have advantage over missing re-excision regarding residual tumor. Furthermore, after adjusting for different variables, especially patients with T1-tumors had a slightly significant benefit from CMS. Discussion: Or study suggests that only certain patients who underwent breast conserving surgery benefit from CMS compared to the standard technique of doing re-excision depending on intraoperative sonography/ mammography. Patients with smaller tumors showed to have a significant benefit from CMS. In all other subgroups using one surgical technique or another did not offer any significant advantage. Regarding the risk of residual tumor after BCS, older patients (specially > 70 years) appear to have less residual tumor than younger ones, maybe due to more extensive excisions. Also, ductal carcinoma in situ showed to have a higher risk of residual tumor as previously described in literature.

Our results indicate a tendency that CMS reduces residual tumor compared to TRE or to no further surgical action, although final results will be presented.

Forum 50.1% and 21.4%, respectively (log rank p < 0.001). After risk adjustment in multivariable analyses, CRS and HIPEC persisted to prove superior to surgery with chemotherapy ( HR 0.529, CI 95% 0.363-0.770, p < 0.001). In addition, significant factors influencing survival were age, tumor histology, presence of extraperitoneal metastases, tumor grading, T and N status, and onset of PC. Discussion: Limitations of the study are the retrospective design with possible bias when estimating therapy-dependent survival, and the lack of a comprehensive recording and use of the Peritoneal Cancer Index ( PCI) for risk adjustment. Conclusion: In line with most randomized and retrospective studies to date, this population-based analysis shows a clear and significant survival benefit of CRS with HIPEC versus surgery followed by chemotherapy.

Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable

Digital health interventions for adolescent and young adult cancer survivors

Digital interventions to support adolescents and young adults with cancer: systematic review

Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment

Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals

A systematic review of the use of the Consolidated Framework for Implementation Research

Steinke I (1995) Qualitative forschung

Gütekriterien und Qualitätssicherung qualitativer Methoden Berlin: Technische Universität Berlin

Effect of cavity margin shavings to ensure completeness of excision on local recurrence rates following breast conserving surgery

Systematic cavity shaving: Modifications of breast cancer management and long-term local recurrence, a multicentre study

Einfluss der Kollagenase des Bakteriums Clostridium Histolyticum auf MCF-7 Brustkrebszellen -in-vitro-und in-vivo-Analyse

Analyse der Versorgungsqualität in einem zertifizierten Pankreaskarzinomzentrum

Innere Klinik (Tumorforschung)

Deutschland Forum Projektes hinaus

Causes of mortality in elderly uicc stage iii colon cancer (cc) patients (pts.)-tumor related death and competing risks from the colopredict plus (cpp) registry

Abteilung für Hämatologie

Abteilung für Onkologie, Hämatologie und Palliativmedizin

Background: Due to insufficient and conflicting prospective evidence, the recommendations on when to apply adjuvant radiochemotherapy in early-stage cervical cancer vary between international guidelines. In this population-based study, we evaluated the outcome of patients with earlystage cervical cancer based on risk factors and the adjuvant therapy they received. Methods: The effect of primary therapy (surgery and radiochemotherapy RCT, surgery and radiotherapy RT, and surgery alone) on overall survival ( OS) and recurrence-free survival ( RFS) was evaluated in the complete cohort of 442 patients and in subgroups according to risk profile and nodal status. Results: In low-risk patients, there was no difference in OS (p = 0.276) depending on whether patients received adjuvant therapy or not. Concerning RFS, patients with RT (including one patient with RCT) exhibited a significantly worse outcome compared to the group with surgery alone (p = 0.015). In intermediate risk patients, the administration of adjuvant RT significantly benefited RFS when compared to surgery only in multivariable analysis (p = 0.031). Concerning OS, no significant influence for adjuvant treatment could be seen (p = 0.354). Though trends towards better OS and RFS could be observed in patients of the high-risk group-both in RCT and RT groups compared to surgery alone-the effects did not prove to be significant. Conclusion: Our study reaffirms the evidence against the use of adjuvant radio(chemo)therapy in low-risk early-stage cervical cancer. In intermediate, and less pronounced in high-risk patients, however, it seems to be beneficial. The role of adjuvant radio(chemo)therapy in early cervical cancer should be further investigated in prospective randomized trials.Anna-Maria Seckler* 1, 2, 3, 4 , Yannick Diehm 1, 2, 3, 4 Hintergrund: Die Kapselfibrose ist eine der häufigsten Komplikationen nach Implantat-basierter Brustrekonstruktion. Neben den bisher angewandten chirurgischen Therapien stellt die Injektion der Kollagenase des Bakteriums Clostridium histolyticum ( CCH) eine potenzielle minimalinvasive Alternative dar. Da die CCH-Injektionen vor allem für Tumorpatientinnen nach Mastektomie und Rekonstruktion eine relevante Therapieoption bietet, muss vor der klinischen Anwendung der Einfluss der Kollagenase auf potenzielle residuale Brustkrebszellen untersucht werden. Methoden: MCF-7 Brustkrebszellen wurden in-vitro mit unterschiedlichen Konzentrationen CCH inkubiert. Zur Untersuchung der Proliferationsfähigkeit der Tumorzellen wurde ein MTT-Assay durchgeführt. Mithilfe des Hoechst-Assays wurde die Tumorzell-Morphologie nach Inkubation mit CCH evaluiert. Um den zugrundeliegenden Mechanismus möglicher Veränderungen der Zellproliferation genauer zu beurteilen, wurden eine Zellzyklusanalyse und ein Apoptose-Assay mittels FACS durchgeführt. Die Zellmigration spielt eine bedeutende Rolle in der Tumorgenese und Metastasierung. Diese wurde anhand des Transwell-Migration-und des Scratch-Assays untersucht. Im Tierversuchsmodell wurden MCF-7 Zellen in immun-defiziente Mäuse implantiert, um einen subkutanen Tumor zu induzieren. Nach Ausbildung des Tumors erfolgte die Injektion der CCH in und um den Tumor in 4